Merck convinced a federal judge to toss claims alleging that it failed to properly warn patients of potential risks related ...

Gilead said two experimental once-a-year versions of its HIV prevention shot lenacapavir passed muster in an early-stage ...

Trump admin's FDA medical product review units remain protected from cuts, while Marty Makary awaits confirmation as ...

Arvinas/Pfizer's vepdegestrant shows efficacy in mutated breast cancer patients but not in broader population, failing to ...

For­mer Ae­tion CEO Car­olyn Mag­ill has joined dig­i­tal health ven­ture firm De­fine Ven­tures as a ven­ture part­ner. It’s ...

Merck has opened a new vaccine manufacturing plant at its existing site in Durham, NC, which will make a shot that is an ...

After months of reports that Walgreens was looking to go private, the retail pharmacy giant (to some folks’ surprise) managed ...

Bristol Myers Squibb will acquire its CAR-T cell therapy collaborator 2seventy bio for $286 million in cash, the companies ...

Emergent BioSolutions sells Baltimore facility to Syngene International for $36.5M; site previously mixed J&J and AstraZeneca ...

Virtual physical therapy startup Hinge Health on Monday filed to go public, snapping a dry spell of digital health IPOs.

Mineralys Therapeutics plans $250M share offering after lorundrostat's Phase 3 success; Coherus cuts 30% staff; BioNTech's melanoma trial fails ...

Endo is selling its international pharmaceuticals business to Knight Therapeutics, a Montreal-based specialty pharma company.